GB Sciences and NRC Research Institute Apply Crowdsourcing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
GB Sciences and NRC Research Institute Apply Crowdsourcing and Big Data Analytics to the Discovery and Validation of Cannabis-Based Therapies

LAS VEGAS, Nov. 10, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, and NRC Research Institute ("NRC") announce the joint development of a crowdsourcing application to discover cannabis-based therapeutic combinations that are effective in the treatment of serious disorders. The app uses real-time patient feedback, impairment testing, and biometric measurements to assess the efficacy of therapeutic products made with prescreened cannabis strains.

"Patients need help in finding the correct strain of Cannabis to treat their medical conditions," said Andrea L. Small-Howard, PhD, MBA, Chief Science Officer of GB Sciences. "Because GB Sciences has a suite of proprietary GrowBLOX TM technologies designed to produce consistent, medical-grade cannabis products with known cannabinoid-terpene profiles, we will soon be able to correlate patient symptoms and pathology with the right 'cocktails' of active ingredients for the first time. Any trial that has tested cannabis-based products without controlling the levels of active ingredients in the plant strains cannot accurately gauge their medicinal value. Once cannabis cocktail mixtures are validated as effective, they will become the source of our novel cannabinoid therapies. The app is our Drug Discovery Engine."

The research firms anticipate thousands of patients will download and use their free electronic Patient Reported Outcomes (GBLX-PRO) app to report and track their experience with different pre-screened strains of medicinal cannabis that are provisionally assigned to seven different treatment categories. In addition, the anonymously collected patient data will contribute to cannabis research and enable GB Sciences to demonstrate which of its pre-screened strains are effective in treating medical conditions such as Parkinson's disease, epilepsy, anxiety, insomnia, pain and metabolic disorders. The GBLX-PRO app will aid in creating personalized treatments for patients with unmet clinical needs.

"This exciting strategic partnership with GB Sciences provides for the successful development of their product pipeline and will help innovate measurements for high-priority therapeutic indications in the cannabis drug development process," said Tony Ortiz, Ph.D., CEO of NRC Research Institute.

Collection and analysis of the two sets of data—cannabis strain potency and patient response to therapy—will enable GB Sciences to monitor and validate dosage levels and their effectiveness in treating specific medical conditions. The GBLX-PRO app will allow for three levels of participation: 1) self-reporting of clinical results using validated surveys; 2) participation in objective impairment testing; and 3) the collection of biometric data voluntarily submitted by participating patients via smartphone accessories. The GBLX-PRO app collects and combines rich objective and subjective patient feedback with lot-specific growth data that GB Sciences collects from its cannabis-growing operations.

"Crowdsourcing efficacy data is now possible because 23 states and Washington, D.C. allow patients to use cannabis," said Craig Ellins, CEO of GrowBLOX Sciences. "When collected and properly analyzed in our big data program, the patient information will provide a roadmap pointing which direction we need to head to treat specific illnesses. For the first time, we are going to have the ability to validate our strains for specific disorders."

To learn more about GB Sciences, Inc., go to www.gbsciences.com .

About GrowBLOX Sciences, Inc.

GB Sciences is a biopharmaceutical research and development company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

About NRC Research Institute

NRC Research is a Clinical Research and Development company with a focus on Contract Research Organization services to the pharmaceuticals and biotechnology companies. NRC Research Institute has worked with numerous globally recognized pharmaceutical and biotechnology companies on the development of experimental medications for FDA approval and other clinical development services.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Media and Investor Relations Contact: Stephen Hart Hayden IR 917-658-7878

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 29

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 5

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 14

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 129

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 91

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 51

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 157

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 265

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 134

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Digital Twin Advancements in Aerospace and Defense

Updated Category News Views 435

Innovations in Digital Twin Technology for Aerospace and Defense In the fast-evolving world of technology, digital twins have emerged as a transformative asset, especially in the Aerospace and Defense sectors. Recently, the Digital Twin Consortium (DTC) has published an insightful whitepaper titled Aerospace-Defense: Digital Twin Research and Technology Gap Analysis. This...

Continue Reading
Arlo Technologies to Showcase Innovations at Upcoming Conference

Updated Category News Views 126

Arlo Technologies to Present at Piper Sandler Growth Frontiers Conference Arlo Technologies, Inc. (NYSE: ARLO), a top contender in the smart home security landscape, is gearing up to showcase its latest achievements at the Piper Sandler Growth Frontiers Conference. This esteemed event highlights innovative companies leading the way in technology, and Arlo is set to make a...

Continue Reading
Plug's Innovative Trade Desk Revolutionizes EV Market Dynamics

Updated Category News Views 833

Plug's Groundbreaking Initiatives in the Electric Vehicle Sector With a substantial seed funding of $6.7 million, Plug is making significant waves in the electric vehicle (EV) market by launching its pioneering Trade Desk. This service is tailored exclusively for EVs, setting a new precedent in the automotive industry, as it allows dealerships to assess, price, and...

Continue Reading
Exciting Winter and Spring Events at Long Island Aquarium

Updated Category News Views 215

Exciting Upcoming Events at Long Island Aquarium The Long Island Aquarium is thrilled to share its lineup of engaging events for winter and spring. Visitors can expect a variety of experiences designed to entertain the whole family. Whether you're a local resident or just visiting, there's something for everyone at this spectacular underwater haven. Culinary Delights...

Continue Reading
Bakkt Holdings, Inc. Announces Third Quarter Earnings Call

Updated Category News Views 91

Bakkt Holdings, Inc. Sets Conference Call for Q3 Earnings Bakkt Holdings, Inc. (NYSE: BKKT) is making waves as it prepares to discuss its financial results for the third quarter of 2024. The company has scheduled the earnings announcement for a date soon approaching, promising insights that will interest investors and analysts alike. Details of the Earnings Call The...

Continue Reading